188 related articles for article (PubMed ID: 17296477)
21. Moroccan Women's Attitudes Regarding Pap Smear Test and Adherence to Cervical Cancer Screening.
Yacouti A; Baddou R; El Mettat K; Guennouni M; El Got A; Aquil A; Ennaji MM; Boumba ALM; Benider A; Mouallif M
J Cancer Educ; 2023 Oct; 38(5):1649-1655. PubMed ID: 37418146
[TBL] [Abstract][Full Text] [Related]
22. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
23. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
24. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
25. [Early detection of cervical cancer in Germany: evidence and implementation].
Seifert U; Klug SJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):294-301. PubMed ID: 24562703
[TBL] [Abstract][Full Text] [Related]
26. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
29. Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.
Huang AJ; Pérez-Stable EJ; Kim SE; Wong ST; Kaplan CP; Walsh JM; Iwaoka-Scott AY; Sawaya GF
J Gen Intern Med; 2008 Sep; 23(9):1324-9. PubMed ID: 18506546
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening in the United States and the Netherlands: a tale of two countries.
Habbema D; De Kok IM; Brown ML
Milbank Q; 2012 Mar; 90(1):5-37. PubMed ID: 22428690
[TBL] [Abstract][Full Text] [Related]
31. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
Ogilvie G; Nakisige C; Huh WK; Mehrotra R; Franco EL; Jeronimo J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():15-19. PubMed ID: 28691338
[TBL] [Abstract][Full Text] [Related]
32. [Pap Smear after 65 years].
Enderle I; Le Baccon FA; Pinsard M; Joueidi Y; Lavoué V; Levêque J; Nyangoh Timoh K
Gynecol Obstet Fertil Senol; 2017 Sep; 45(9):478-485. PubMed ID: 28864050
[TBL] [Abstract][Full Text] [Related]
33. Cervical Cancer Screening-Past, Present, and Future.
Wentzensen N; Clarke MA
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):432-434. PubMed ID: 33857013
[TBL] [Abstract][Full Text] [Related]
34. [Cervical cancer screening in Germany].
Bujan Rivera J; Klug SJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1528-1535. PubMed ID: 30397722
[TBL] [Abstract][Full Text] [Related]
35. [Cervical-vaginal smears: an unpopular test!].
Gompel C
Presse Med; 1998 Jun; 27(20):971-3. PubMed ID: 9767844
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening: A never-ending developing program.
Comparetto C; Borruto F
World J Clin Cases; 2015 Jul; 3(7):614-24. PubMed ID: 26244153
[TBL] [Abstract][Full Text] [Related]
37. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
[TBL] [Abstract][Full Text] [Related]
38. Understanding women's hesitancy to undergo less frequent cervical cancer screening.
Gerend MA; Shepherd MA; Kaltz EA; Davis WJ; Shepherd JE
Prev Med; 2017 Feb; 95():96-102. PubMed ID: 27932055
[TBL] [Abstract][Full Text] [Related]
39. The present and future of cervical cancer screening programmes in Europe.
Giorgi Rossi P; Ronco G
Curr Pharm Des; 2013; 19(8):1490-7. PubMed ID: 23016782
[TBL] [Abstract][Full Text] [Related]
40. Update on current care guideline: Cytological changes in the cervix, vagina and vulva.
Duodecim; 2017; 133(2):183-5. PubMed ID: 29205018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
